ConductScience.org, home

Paper23745006

Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.

Nunes S and 3 others. Invest Ophthalmol Vis Sci, 2013. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema. Papers, record 23745006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23745006

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.
PubMed
Journal
Invest Ophthalmol Vis Sci
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2022-04-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nunes SSandrina
2Ribeiro LLuisa
3Lobo CConceição
4Cunha-Vaz JJosé

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetic RetinopathyMajor topic
Macular EdemaMajor topic
Aged
Cluster Analysis
Diabetes Mellitus, Type 2
Disease Progression
Female
Humans
Male
Middle Aged
Phenotype
Prospective Studies
Risk Factors
Tomography, Optical Coherence
Visual Acuity

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00763802Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2Derived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
41693808The Association of Lapses in Diabetic Retinopathy Care with Vision Impairment.Ophthalmol Sci2026https://conductscience.org/library/papers/41693808PubMed
40646245Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging.Eye (Lond)2025https://conductscience.org/library/papers/40646245PubMed
39061684Distribution of Microaneurysms and Hemorrhages in Accordance with the Grading of Diabetic Retinopathy in Type Diabetes Patients.Diagnostics (Basel)2024https://conductscience.org/library/papers/39061684PubMed
38667478Referable Diabetic Retinopathy Prediction Algorithm Applied to a Population of 120,389 Type 2 Diabetics over 11 Years Follow-Up.Diagnostics (Basel)2024https://conductscience.org/library/papers/38667478PubMed
36494431Perspectives of diabetic retinopathy-challenges and opportunities.Eye (Lond)2023https://conductscience.org/library/papers/36494431PubMed
36185322Recent developments on computer aided systems for diagnosis of diabetic retinopathy: a review.Multimed Tools Appl2023https://conductscience.org/library/papers/36185322PubMed
35757010Retinal Neurodegeneration in Different Risk Phenotypes of Diabetic Retinal Disease.Front Neurosci2021https://conductscience.org/library/papers/35757010PubMed
35158351Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study.Ophthalmologica2022https://conductscience.org/library/papers/35158351PubMed
34865186Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy.Ophthalmol Ther2022https://conductscience.org/library/papers/34865186PubMed
34070479Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study.J Clin Med2021https://conductscience.org/library/papers/34070479PubMed
33706717Population segmentation of type 2 diabetes mellitus patients and its clinical applications - a scoping review.BMC Med Res Methodol2021https://conductscience.org/library/papers/33706717PubMed
33025221Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression.Acta Diabetol2021https://conductscience.org/library/papers/33025221PubMed
32408522Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.J Clin Med2020https://conductscience.org/library/papers/32408522PubMed
32181799Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study.Invest Ophthalmol Vis Sci2020https://conductscience.org/library/papers/32181799PubMed
31388757[Unmet research and developmental needs in ophthalmology : A consensus-based road map of the European Vision Institute for 2019-2025].Ophthalmologe2019https://conductscience.org/library/papers/31388757PubMed
31160916Plasma metabolomic profiling of proliferative diabetic retinopathy.Nutr Metab (Lond)2019https://conductscience.org/library/papers/31160916PubMed
30581604Applications of Artificial Intelligence in Ophthalmology: General Overview.J Ophthalmol2018https://conductscience.org/library/papers/30581604PubMed
29699981Microaneurysm turnover is a predictor of diabetic retinopathy progression.Br J Ophthalmol2019https://conductscience.org/library/papers/29699981PubMed
28729371Geographic atrophy phenotype identification by cluster analysis.Br J Ophthalmol2018https://conductscience.org/library/papers/28729371PubMed
27306616Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes.Diabetologia2016https://conductscience.org/library/papers/27306616PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23745006

GET https://conductscience.org/api/papers/v1/23745006/cited_by?page=2